Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Expert Financial Analysis and Reporting

Expanding on Clinical Trials of CPP-109 in Cocaine Addiction and Pre-Clinical Studies of CPP-115 (CPRX, $1.14)

Purpose of Report
I recently initiated coverage of Catalyst Pharmaceutical Partners (CPRX). This report is a follow-on to that report which…
Read more…

Initiating Coverage Based on Interest in CPP-109 for Treating Cocaine Addiction (CPRX,$1.18)

Company Overview
The US Department of Health and Human Services estimates that there are about 1 million Americans addicted to cocaine…
Read more…